| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Oncology, Markers, Clinical Correlates |
Department of Cancer Cell Biology, Harvard School of Public Health, Boston, Massachusetts 02115 [E. R., E. P., M. H., M. L., K. T. K.]; Department of Oral Epidemiology and Department of Oral Medicine, Harvard School of Dental Medicine, Boston, Massachusetts 02115 [E. P.]; and Department of Head and Neck Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115 [M. P.]
Purpose: Human papillomavirus (HPV) has previously been reported to be associated with squamous cell carcinoma of the head and neck. Our objective was to investigate the presence and type of HPV infection in head and neck tumors and determine whether infection was associated with individual tumor characteristics, patients’ pattern of tobacco and alcohol exposure, or with clinical outcome.
Experimental Design: Using a case series design, fresh tumor samples were obtained from a series of 89 head and neck squamous cell carcinoma patients, including 64 men and 25 women. The majority of tumors were located in the oral cavity, followed by the oropharynx. A PCR-based technique with restriction fragment length polymorphism analysis was used to detect and type HPV.
Results: Of the 89 patients, 18 (20%) had detectable HPV16 in their tumor samples. HPV16 was detected in 64% of tonsil tumors, 52% oropharyngeal tumors, and 5% oral cavity tumors. The mean age of subjects with HPV16-positive tumors was younger than the patients with HPV-negative tumors. Also, this group consumed less alcohol on a weekly basis and had a better clinical outcome compared with the HPV-negative group. Smoking, clinical stage, tumor grade, and tumor-node-metastasis status were not associated with HPV16 presence.
Conclusions: Our study supports the previous reports that suggest HPV16 is associated with squamous cell cancers located in the oropharynx and oral cavity. The fact that HPV-positive tumors were observed in younger, lighter alcohol-consuming individuals with a better overall and disease-specific survival suggests a distinct disease process in these patients.
This article has been cited by other articles:
|
|
 |
|
  F. P. Worden, B. Kumar, J. S. Lee, G. T. Wolf, K. G. Cordell, J. M.G. Taylor, S. G. Urba, A. Eisbruch, T. N. Teknos, D. B. Chepeha, et al. Chemoselection As a Strategy for Organ Preservation in Advanced Oropharynx Cancer: Response and Survival Positively Associated With HPV16 Copy Number J. Clin. Oncol., July 1, 2008; 26(19): 3138 - 3146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Kumar, K. G. Cordell, J. S. Lee, F. P. Worden, M. E. Prince, H. H. Tran, G. T. Wolf, S. G. Urba, D. B. Chepeha, T. N. Teknos, et al. EGFR, p16, HPV Titer, Bcl-xL and p53, Sex, and Smoking As Indicators of Response to Therapy and Survival in Oropharyngeal Cancer J. Clin. Oncol., July 1, 2008; 26(19): 3128 - 3137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Furniss, C. J. Marsit, E. A. Houseman, K. Eddy, and K. T. Kelsey Line Region Hypomethylation Is Associated with Lifestyle and Differs by Human Papillomavirus Status in Head and Neck Squamous Cell Carcinomas Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 966 - 971. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Cobo, P. Talavera, and A. Concha Review Article: Relationship of Human Papillomavirus With Papillary Squamous Cell Carcinoma of the Upper Aerodigestive Tract: A Review International Journal of Surgical Pathology, April 1, 2008; 16(2): 127 - 136. [Abstract] [PDF]
|
|
|
|
 |
|
 X. Ji, A. S. Neumann, E. M. Sturgis, K. Adler-Storthz, K. R. Dahlstrom, J. T. Schiller, Q. Wei, and G. Li p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers Carcinogenesis, April 1, 2008; 29(4): 875 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Ting Hsiung, C. J. Marsit, E. A. Houseman, K. Eddy, C. S. Furniss, M. D. McClean, and K. T. Kelsey Global DNA Methylation Level in Whole Blood as a Biomarker in Head and Neck Squamous Cell Carcinoma Cancer Epidemiol. Biomarkers Prev., January 1, 2007; 16(1): 108 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Licitra, F. Perrone, P. Bossi, S. Suardi, L. Mariani, R. Artusi, M. Oggionni, C. Rossini, G. Cantu, M. Squadrelli, et al. High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma J. Clin. Oncol., December 20, 2006; 24(36): 5630 - 5636. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Tremblay, P. Pintor dos Reis, G. Bradley, N. N. Galloni, B. Perez-Ordonez, J. Freeman, D. Brown, R. Gilbert, P. Gullane, J. Irish, et al. Young Patients With Oral Squamous Cell Carcinoma: Study of the Involvement of GSTP1 and Deregulation of the Fanconi Anemia Genes. Arch Otolaryngol Head Neck Surg, September 1, 2006; 132(9): 958 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Fakhry and M. L. Gillison Clinical Implications of Human Papillomavirus in Head and Neck Cancers J. Clin. Oncol., June 10, 2006; 24(17): 2606 - 2611. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B Perez-Ordonez, M Beauchemin, and R C K Jordan Molecular biology of squamous cell carcinoma of the head and neck. J. Clin. Pathol., May 1, 2006; 59(5): 445 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Weinberger, Z. Yu, B. G. Haffty, D. Kowalski, M. Harigopal, J. Brandsma, C. Sasaki, J. Joe, R. L. Camp, D. L. Rimm, et al. Molecular Classification Identifies a Subset of Human Papillomavirus-Associated Oropharyngeal Cancers With Favorable Prognosis J. Clin. Oncol., February 10, 2006; 24(5): 736 - 747. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bodaghi, L. V. Wood, G. Roby, C. Ryder, S. M. Steinberg, and Z.-M. Zheng Could Human Papillomaviruses Be Spread through Blood? J. Clin. Microbiol., November 1, 2005; 43(11): 5428 - 5434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bodaghi, K. Yamanegi, S.-Y. Xiao, M. Da Costa, J. M. Palefsky, and Z.-M. Zheng Colorectal Papillomavirus Infection in Patients with Colorectal Cancer Clin. Cancer Res., April 15, 2005; 11(8): 2862 - 2867. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Szladek, A Juhasz, G Kardos, K Szoke, T Major, I Sziklai, I Tar, I Marton, J Konya, L Gergely, et al. High co-prevalence of genogroup 1 TT virus and human papillomavirus is associated with poor clinical outcome of laryngeal carcinoma J. Clin. Pathol., April 1, 2005; 58(4): 402 - 405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Mao and W. K. Hong How Does Human Papillomavirus Contribute to Head and Neck Cancer Development? J Natl Cancer Inst, July 7, 2004; 96(13): 978 - 980. [Full Text] [PDF]
|
|
|
|
|
|
B. J. M. Braakhuis, P. J. F. Snijders, W.-J. H. Keune, C. J. L. M. Meijer, H. J. Ruijter-Schippers, C. R. Leemans, and R. H. Brakenhoff Genetic Patterns in Head and Neck Cancers That Contain or Lack Transcriptionally Active Human Papillomavirus J Natl Cancer Inst, July 7, 2004; 96(13): 998 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Ha and J. A. Califano THE ROLE OF HUMAN PAPILLOMAVIRUS IN ORAL CARCINOGENESIS Crit. Rev. Oral. Biol. Med., July 1, 2004; 15(4): 188 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Syrjanen HPV infections and tonsillar carcinoma J. Clin. Pathol., May 1, 2004; 57(5): 449 - 455. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Canadas, F. X. Bosch, M. L. Junquera, M. Ejarque, R. Font, E. Ordonez, and S. de Sanjose Concordance of Prevalence of Human Papillomavirus DNA in Anogenital and Oral Infections in a High-Risk Population J. Clin. Microbiol., March 1, 2004; 42(3): 1330 - 1332. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Dai, G. M. Clifford, F. le Calvez, X. Castellsague, P. J. F. Snijders, M. Pawlita, R. Herrero, P. Hainaut, and S. Franceschi Human Papillomavirus Type 16 and TP53 Mutation in Oral Cancer: Matched Analysis of the IARC Multicenter Study Cancer Res., January 15, 2004; 64(2): 468 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Li, C. H. Thompson, D. Xin, Y. E. Cossart, C. J. O'Brien, E. B. McNeil, K. Gao, R. A. Scolyer, and B. R. Rose Absence of Human Papillomavirus in Tonsillar Squamous Cell Carcinomas from Chinese Patients Am. J. Pathol., December 1, 2003; 163(6): 2185 - 2189. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
